Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia

Michiel Kroesen, Hendrik T. Mulder, Jeanette M. L. van Holthe, Aleida A. Aangeenbrug, Jan Willem M. Mens, Helena C. van Doorn, Margarethus M. Paulides, Esther Oomen-de Hoop, Rene M. Vernhout, Ludy C. Lutgens, Gerard C. van Rhoon, Martine Franckena*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)150-158
Number of pages9
JournalRadiotherapy and Oncology
Volume140
DOIs
Publication statusPublished - Nov 2019

Keywords

  • Hyperthermia
  • Cervical cancer
  • Treatment outcome
  • Thermal dose
  • Trise
  • CEM43T90
  • Image guided brachytherapy
  • GUIDED ADAPTIVE BRACHYTHERAPY
  • CLINICAL IMPLEMENTATION
  • REGIONAL HYPERTHERMIA
  • DEEP HYPERTHERMIA
  • RANDOMIZED-TRIAL
  • CANCER
  • RADIOTHERAPY
  • TIME
  • RADIOCHEMOTHERAPY
  • TEMPERATURE

Cite this

Kroesen, M., Mulder, H. T., van Holthe, J. M. L., Aangeenbrug, A. A., Mens, J. W. M., van Doorn, H. C., Paulides, M. M., Oomen-de Hoop, E., Vernhout, R. M., Lutgens, L. C., van Rhoon, G. C., & Franckena, M. (2019). Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia. Radiotherapy and Oncology, 140, 150-158. https://doi.org/10.1016/j.radonc.2019.06.021